Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T...
Bullish - IHS formation - Broke downward trend line & retest - Funds accumulating - Decent fundamentals Entry idea - For members Stop loss depending on entry and risk appetite. But always set meaningful stops. "if you don't find a way to make money while you sleep. You will work until you die.” Cheers and happy trading!
The most recent candle tested four fibonacci levels and closed at the .618 level. The D+ recently crossed D- on the ADX and the Force Index, long and short term turned positive. There is bullish divergence with the OBV up while price declined from 8/9-8/23. Looking for a short term swing trade with a 1.5XATR stop and a target of $8.84
I Like the way this has bottomed out through price action, give it a week and it should be good to trade. RSI7 is going to come around, just look at it last time.
Believing B/C pivot just happened and we are moving down. Since we recover to ~ 0.618 of A we may reach new lows in this run downwards. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to...